Bristol-Myers' Opdivo gets into high gear for new melanoma approval
admin 18th October 2017 Uncategorised 0Bristol-Myers Squibb won its first Opdivo approval in melanoma, and the drug has been racking up new uses in that disease ever since. Now, it’s up for a potentially speedy approval to prevent the cancer’s return after surgery.
More: Bristol-Myers' Opdivo gets into high gear for new melanoma approval
Source: fierce